spiperone has been researched along with Dyskinesia, Drug-Induced in 32 studies
Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
Excerpt | Relevance | Reference |
---|---|---|
" Chronic administration of ceruletide (160 micrograms." | 1.29 | Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile. ( Asanuma, M; Hirata, H; Mori, A; Ogawa, N; Ota, Z, 1993) |
"Treatment with molindone for 14 days at 3, 6, 20 and 40 mg/kg, enhanced the stereotyped behavioral response induced by apomorphine and increased the numbered of D-2 dopamine receptors in the striatum (Bmax) labelled by high affinity (Kd = 40 pmol) binding or [3H] spiroperidol in the guinea-pig." | 1.27 | Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia. ( Curtin, J; Fields, J; Koller, W, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (75.00) | 18.7374 |
1990's | 7 (21.88) | 18.2507 |
2000's | 1 (3.13) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, H | 1 |
Ma, L | 1 |
Wang, F | 1 |
Chen, J | 1 |
Zhen, X | 1 |
Waddington, JL | 2 |
Cross, AJ | 3 |
Gamble, SJ | 1 |
Bourne, RC | 1 |
Wagner, HN | 1 |
Mishra, RK | 1 |
Rosengarten, H | 2 |
Schweitzer, JW | 3 |
Friedhoff, AJ | 3 |
Koller, W | 1 |
Curtin, J | 1 |
Fields, J | 1 |
Bédard, PJ | 2 |
Boucher, R | 2 |
Daigle, M | 1 |
Di Paolo, T | 3 |
Bhargava, HN | 1 |
Bannet, J | 1 |
Belmaker, RH | 1 |
Ebstein, RP | 1 |
Crow, TJ | 2 |
Johnstone, EC | 2 |
Owen, F | 2 |
Owens, DG | 2 |
Schwartz, R | 1 |
Clow, A | 1 |
Theodorou, A | 1 |
Jenner, P | 1 |
Marsden, CD | 1 |
Hirata, H | 1 |
Ogawa, N | 1 |
Asanuma, M | 1 |
Ota, Z | 1 |
Mori, A | 1 |
Bossé, R | 1 |
DiPaolo, T | 1 |
Jeanjean, AP | 1 |
Laterre, EC | 1 |
Maloteaux, JM | 1 |
Maj, J | 1 |
Rogóz, Z | 1 |
Skuza, G | 1 |
Kołodziejczyk, K | 1 |
List, SJ | 1 |
Seeman, P | 2 |
Eibergen, RD | 2 |
Carlson, KR | 2 |
Coppens, HJ | 1 |
Slooff, CJ | 1 |
Paans, AM | 1 |
Wiegman, T | 1 |
Vaalburg, W | 1 |
Korf, J | 1 |
Fields, JZ | 1 |
Drucker, GE | 1 |
Wichlinski, L | 1 |
Gordon, JH | 1 |
Andersson, U | 1 |
Eckernäs, SA | 1 |
Hartvig, P | 1 |
Ulin, J | 1 |
Långström, B | 1 |
Häggström, JE | 1 |
See, RE | 1 |
Aravagiri, M | 1 |
Ellison, GD | 1 |
Kornhuber, J | 1 |
Riederer, P | 1 |
Reynolds, GP | 1 |
Beckmann, H | 1 |
Jellinger, K | 1 |
Gabriel, E | 1 |
Blin, J | 1 |
Baron, JC | 1 |
Cambon, H | 1 |
Bonnet, AM | 2 |
Dubois, B | 1 |
Loc'h, C | 1 |
Mazière, B | 1 |
Agid, Y | 2 |
Ferrier, IN | 1 |
Johnson, JA | 1 |
Poulter, M | 1 |
Egawa, M | 1 |
Ruberg, M | 1 |
Javoy-Agid, F | 1 |
Falardeau, P | 2 |
Bouchard, S | 1 |
Twery, MJ | 1 |
Kirkpatrick, B | 1 |
Critcher, EC | 1 |
Lewis, MH | 1 |
Mailman, RB | 1 |
Cooper, CW | 1 |
1 review available for spiperone and Dyskinesia, Drug-Induced
Article | Year |
---|---|
CNS dopamine receptors: effect of prolyl-leucyl-glycinamide and solubilization.
Topics: Adenylyl Cyclases; Animals; Binding Sites; Brain; Cattle; Dopamine; Dopamine Antagonists; Dyskinesia | 1984 |
31 other studies available for spiperone and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Disease M | 2007 |
Dopamine receptor function and spontaneous orofacial dyskinesia in rats during 6-month neuroleptic treatments.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Dyskinesia, Drug-Induced; Humans; Male | 1983 |
Imaging CNS receptors: the dopaminergic system.
Topics: Animals; Antipsychotic Agents; Apomorphine; Binding Sites; Brain; Carbon Radioisotopes; Deoxyglucose | 1984 |
Induction of oral dyskinesias in naive rats by D1 stimulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Dysk | 1983 |
Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia.
Topics: Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Guinea Pigs | 1984 |
Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys.
Topics: Animals; Apomorphine; Drug Interactions; Dyskinesia, Drug-Induced; Estradiol; Female; Haloperidol; M | 1984 |
Cyclo(Leu-Gly): a possible treatment for tardive dyskinesia?
Topics: Animals; Apomorphine; Corpus Striatum; Dipeptides; Drug Tolerance; Dyskinesia, Drug-Induced; Haloper | 1983 |
The effect of drug holidays in an animal model of tardive dyskinesia.
Topics: Animals; Corpus Striatum; Dopamine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperi | 1980 |
Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors?
Topics: Adult; Aged; Brain; Dyskinesia, Drug-Induced; Female; Flupenthixol; Humans; Male; Middle Aged; Mouth | 1982 |
Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
Topics: Animals; Corpus Striatum; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Rats; Rats, Inbred St | 1982 |
Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Brain; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; | 1980 |
Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Blotting, Northern; Ceruletide; Corpus Striat | 1993 |
The modulation of brain dopamine and GABAA receptors by estradiol: a clue for CNS changes occurring at menopause.
Topics: Animals; Anti-Anxiety Agents; Autoradiography; Benzazepines; Binding Sites; Brain; Brain Chemistry; | 1996 |
Neuroleptic binding to sigma receptors: possible involvement in neuroleptic-induced acute dystonia.
Topics: Animals; Antipsychotic Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Male; Piperidines; Quinu | 1997 |
The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Topics: Animals; Antiparkinson Agents; Benzazepines; Benzothiazoles; Body Temperature; Catalepsy; Clozapine; | 1997 |
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Corpus Striatum; Dyskinesia, Drug-Induced; Haloperid | 1979 |
Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Dyskinesia, Drug-Induced; Haloperidol; Haplorhini; Hum | 1976 |
Susceptibility to amphetamine-elicited dyskinesias following chronic methadone treatment in monkeys.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Drug Interactions; Dyskinesia, Drug-Induced; Haloperid | 1976 |
High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Brain; Dyskinesia, Drug-Induced; Female; Humans; Male; Psychiatric Stat | 1991 |
Neurochemical basis for the absence of overt "stereotyped" behaviors in rats with up-regulated striatal D2 dopamine receptors.
Topics: Animals; Antipsychotic Agents; Apomorphine; Corpus Striatum; Dyskinesia, Drug-Induced; Kinetics; Rat | 1991 |
Striatal binding of 11C-NMSP studied with positron emission tomography in patients with persistent tardive dyskinesia: no evidence for altered dopamine D2 receptor binding.
Topics: Aged; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Receptors, Dopamine; Receptors, D | 1990 |
Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors.
Topics: Animals; Autoradiography; Behavior, Animal; Benzazepines; Brain; Disease Models, Animal; Dyskinesia, | 1989 |
3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Male; Middl | 1989 |
Striatal dopamine D2 receptors in tardive dyskinesia: PET study.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Brain; Cerebellum; Corpus Striatum; Delirium; Dementi | 1989 |
Chemical and structural changes in the brain in patients with movement disorder.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Antipsychotic Agents; Brain; Choline O-Acetyltransfer | 1985 |
Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Disease Models, A | 1988 |
Pathophysiology of L-dopa-induced abnormal involuntary movements.
Topics: Brain; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Neural Pathways; Parki | 1985 |
Brain dopamine receptors in schizophrenia and tardive dyskinesia.
Topics: Acetylcholine; Animals; Brain; Caudate Nucleus; Dopamine; Dyskinesia, Drug-Induced; Humans; Kinetics | 1985 |
Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzaze | 1988 |
Motor effects of calcitonin administered intracerebroventricularly in the rat.
Topics: Animals; Behavior, Animal; Calcitonin; Cerebral Ventricles; Corpus Striatum; Dopamine; Dyskinesia, D | 1986 |
Modulation of brain and pituitary dopamine receptors by estrogens and prolactin.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Estradiol; Estrogens; Fe | 1985 |